Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life
- Conditions
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-07-25
- Target Recruit Count
- 170
- Registration Number
- NCT06026644
- Locations
- 🇮🇹
Aou Di Bologna - Policlinico S. Orsola-malpighi - Uoc Ematologia, Bologna, Italy
🇮🇹AOU Careggi - SOD terapie cellulari e Medicina Trasfusionale, Firenze, Italy
🇮🇹Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Ad Indirizzo Oncologico, Palermo, Italy
Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment
- Conditions
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2023-09-07
- Target Recruit Count
- 736
- Registration Number
- NCT06028087
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-04-11
- Target Recruit Count
- 158
- Registration Number
- NCT06025682
- Locations
- 🇮🇹
UOC Ematologia Fondazione Policlinico Universitario A.Gemelli, Roma, Italy
Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study
- Conditions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2023-12-29
- Target Recruit Count
- 96
- Registration Number
- NCT05927558
- Locations
- 🇮🇹
Ematologia Istituto Nazionale Tumori, Milano, Italy
Real World Evidence of Fedratinib Effectiveness in MF
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2024-02-08
- Target Recruit Count
- 93
- Registration Number
- NCT05883904
- Locations
- 🇮🇹
Ematologia FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO, Milano, Italy
Novel Approaches to Target MECOM/EVI1 in AML
- Conditions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-12-29
- Target Recruit Count
- 24
- Registration Number
- NCT05839392
- Locations
- 🇮🇹
Ematologia, Piacenza, Italy
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
- Conditions
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2023-11-28
- Target Recruit Count
- 954
- Registration Number
- NCT05803395
- Locations
- 🇮🇹
UOC Ematologia AO Cosenza, Cosenza, Italy
🇮🇹Ematologia AOU S.Anna, Ferrara, Italy
🇮🇹Ematologia AOU Careggi, Firenze, Italy
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
- Conditions
- Interventions
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2023-12-01
- Target Recruit Count
- 45
- Registration Number
- NCT05694312
- Locations
- 🇮🇹
Ematologia Osp Molinette, Torino, Italy
🇮🇹Ematologia Osp Careggi, Firenze, Italy
🇮🇹Ematologia Osp Maggiore della Carità, Novara, Italy
Biologic Characterization of Patients With ITP
- Conditions
- Interventions
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2024-05-21
- Target Recruit Count
- 200
- Registration Number
- NCT05694325
- Locations
- 🇮🇹
Sc Ematologia Ospedale S.G. Battista Molinette - Università Degli Studi Di Torino, Torino, Italy
🇮🇹SC Ematologia ASUGI, Trieste, Italy
🇮🇹Ematologia e centro trapianti ASL Piacenza, Piacenza, Italy
Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP
- Conditions
- Interventions
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-01-13
- Target Recruit Count
- 47
- Registration Number
- NCT05613296